Toxoplasmosis and its Ocular Manifestations

1. Foudrinier, F., I. Villena, R. Jaussaud et D. Aubert. Clinical Value of Specifi c Immunoglobulin E Detection by Enzyme-Linked Immunosorbent Assay in Cases of Acquired and Congenital Toxoplasmosis, 41, 2003, № 4, 1681-1686.10.1128/JCM.41.4.1681-1686.200315389012682160Search in Google Scholar

2. Christopher, D. et al. Hunter Immune response and immunopathology during toxoplasmosis Semin Immunopathol. - Semin Immunopathol., 34, 2012, № 6, 793-813.10.1007/s00281-012-0339-3349859522955326Search in Google Scholar

3. Louis , M. Toxoplasmosis: a history of clinical observations. - Int. J. Parasitol., 39, 2009, № 8, 895-901.10.1016/j.ijpara.2009.02.004270402319217908Search in Google Scholar

4. Sterers , Y., F. Pratlong et S. Albaba. Novel Interpretation of Molecular Diagnosis of Congenital Toxoplasmosis According to Gestational Age at the Time of Maternal Infection, 50, 2012, № 12, 3944-3951.10.1128/JCM.00918-12350294423035201Search in Google Scholar

5. Willerson J r. , D. et al. Unusual ocular presentation of acute toxoplasmosis. - Br. J. Ophthalmol., 61, 1977, № 11, 693-698.10.1136/bjo.61.11.6931043099588525Search in Google Scholar

6. Charles , J. Kipp, Hemorrhagic Central Chorioretinitis in Non-myopic Eyes: A Clinical Contribution. - Trans. Am. Ophthalmol. Soc., 12, 1909, (Pt 1), 250-266.Search in Google Scholar

7. Turunen , H. J., P. O. Leinikki, K. M. Saari. Demonstration of intraocular synthesis of immunoglobulin G toxoplasma antibodies for specifi c diagnosis of toxoplasmicchorioretinitis by enzyme immunoassay. - J. Clin. Microbiol., 17, 1983, № 6, 988-992.10.1128/jcm.17.6.988-992.19832727886348082Search in Google Scholar

8. Florence Robert-Gangneux, Marie-Laure Dardé. Epidemiology of and Diagnostic Strategies for Toxoplasmosis. - Clin. Microbiol. Rev., 25, 2012, № 3, 583.10.1128/CMR.00026-12Search in Google Scholar

9. Villard , O. et al. J Clin Microbiol, Comparison of Enzyme-Linked Immunosorbent Assay, Immunoblotting, and PCR for Diagnosis of Toxoplasmic Chorioretinitis, 41, 2003, № 8, 3537-3541.10.1128/JCM.41.8.3537-3541.200317981712904352Search in Google Scholar

10. Connor, G. R. O. The infl eunce of hypersensitivity on the pathogenesis of ocular toxoplasmosis. - Trans. Am. Ophthalmol. Soc., 68, 1970, 501-547.Search in Google Scholar

11. Gwendolyn Noble , A. Paul Latkany, Jaroslaw Kusmierczyk, the Toxoplasmosis Study Group, Chorioretinal lesions in mothers of children with congenital toxoplasmosis in the National Collaborative Chicago-based, CongenitalToxoplasmosis Study. - Sci. Med. (Porto Alegre), 20, 2010, № 1, 20-26.10.15448/1980-6108.2010.1.5930Search in Google Scholar

12. McLeod , R. et al. Mem Inst Oswaldo Cruz, Why prevent, diagnose and treat congenital toxoplasmosis? - Mem. Inst. Oswaldo Cruz., 104, 2009, № 2, 320-344.10.1590/S0074-02762009000200029273510219430661Search in Google Scholar

13. Stillwaggon , E. et al. PLoS Negl Trop Dis, Maternal Serologic Screening to Prevent Congenital Toxoplasmosis: A Decision-Analytic Economic Model, 5, 2011, № 9, e1333.10.1371/journal.pntd.0001333318124121980546Search in Google Scholar

14. McLeod , R. et al. Why prevent, diagnose and treat congenital toxoplasmosis? - Mem. Inst. Oswaldo Cruz., 104, 2009, № 2, 320-344.10.1590/S0074-02762009000200029Search in Google Scholar

15. Young- Hoon Park, Ho-Woo Nam, Clinical Features and Treatment of Ocular Toxoplasmosis. - Korean J. Parasitol., 51, 2013, № 4, 393-399. 10.3347/kjp.2013.51.4.393377086924039281Search in Google Scholar